Insulet Canada Corporation
Registration:
1
of
1
(2026-02-19
to
present)
Details Regarding the Identified Subject Matter
|
Specific Topics of Lobbying Communications
|
Intended Outcomes
|
Associated Subject Matters
|
To inform elected officials and senior decision makers of the Omnipod 5 insulin pump technology in the treatment of diabetes; to promote market access to new and emerging devices and technology, including pharmacare
|
Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation
|
Finances and Budgets, Health
|